<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Multifactorial Model of Organotropism Incorporating Anatomical, Exosomal/PMN and Tumor-Intrinsic Programs - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Theory Details for theory-45</h1>

        <div class="section">
            <h2>Theory (General Information)</h2>
            <div class="info-section">
                <p><strong>ID:</strong> theory-45</p>
                <p><strong>Name:</strong> Multifactorial Model of Organotropism Incorporating Anatomical, Exosomal/PMN and Tumor-Intrinsic Programs</p>
                <p><strong>Type:</strong> general</p>
                <p><strong>Theory Query:</strong> Build a theory of the best explanation for preferential metastatic organotropism of different cancers, based on the following results.</p>
                <p><strong>Description:</strong> Preferential metastatic organotropism emerges from the dynamic integration of three major determinants: (1) anatomical and hemodynamic factors (route of venous/lymphatic drainage, mechanical trapping); (2) exosome/PMN-driven microenvironmental conditioning (as above); and (3) tumor-intrinsic molecular programs (epigenetic, transcriptional, and functional plasticity that enable adaptation to specific niches, including neuronal/ECM mimicry, stemness, nuclear mechanics, and EMT status). The combined, context-specific output of these interacting axes specifies the eventual pattern and efficiency of metastasis to particular organs.</p>
                <p><strong>Knowledge Cutoff Year:</strong> 2029</p>
                <p><strong>Knowledge Cutoff Month:</strong> 12</p>
                <p><strong>Base Model:</strong> openai/gpt-4.1-2025-04-14</p>
            </div>
        </div>
        </div>

        <div class="section">
            <h2>Theory (Statement/Laws)</h2>

            <h3>Theory Statements/Laws</h3>
            <hr/>
            <h3>Statement 0: Anatomical/Vascular Route Determinant Law</h3>
            <p><strong>Statement:</strong> Venous and lymphatic drainage patterns, and capillary bed architecture, set the first-level probability for organotropic metastatic seeding through mechanical trapping of circulating tumor cells (CTCs), particularly for organs like liver and lung with large first-pass blood supply or connections (e.g., via portal vein or Batson's plexus).</p>
            <p><strong>Domain/Scope:</strong> Applies broadly to all cancers where mechanical trapping/circulation determines early phase DTC/CTC arrest; especially relevant to colorectal-to-liver, rectum-to-lung, and prostate-to-spine patterns.</p>
            <h4>Special Cases</h4>
            <ol>
                <li>Circulatory pattern is necessary but not sufficient: microenvironmental compatibility must also exist.</li>
                <li>Anatomical shunts, vascular diseases (e.g., portal hypertension), or surgical alterations can modify expected patterns.</li>
            </ol>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Autopsy, clinical, and epidemiological data demonstrate dominant seeding patterns explained by anatomy (e.g., colorectal cancer to liver via portal drainage, prostate to spine via Batson's plexus, frequency matching venous plumbing). <a href="../results/extraction-result-175.html#e175.2" class="evidence-link">[e175.2]</a> <a href="../results/extraction-result-173.html#e173.6" class="evidence-link">[e173.6]</a> </li>
    <li>SEER and pathology studies provide frequency data matching venous routes (higher liver metastasis from proximal colon/rectum, higher lung from distal rectum/anus). <a href="../results/extraction-result-175.html#e175.2" class="evidence-link">[e175.2]</a> </li>
</ol>            <h4>Self-Evaluation of Law Novelty (produced by the generation model)</h4>
            <p><strong>Likely Classification:</strong> existing</p>
        <p><strong>Explanation:</strong> While the law itself is pre-existing, its contextual placement as one axis within a complex model is more recent.</p>            <p><strong>What Already Exists:</strong> Anatomical/circulatory models of organotropism are classic (e.g., Ewing's mechanical theory).</p>            <p><strong>What is Novel:</strong> The law's integration with—and recognition of limitations compared to—PMN and tumor intrinsic adaptation as co-determinants in modern multifactorial models is explicit.</p>
        <p><strong>References:</strong> <ul>
    <li>Ewing (1928) Neoplastic Diseases [mechanical theory of metastasis]</li>
    <li>Qiu (2015) Pattern of distant metastases in colorectal cancer: a SEER-based study [epidemiological support]</li>
</ul>
            <h4>External Evaluations of this Law</h4>
            <p><strong>Predictive Accuracy Evaluation:</strong> <span class="empty-note">Not available.</span></p>
            <p><strong>Novelty Evaluation:</strong> <span class="empty-note">Not available (available only for a randomly selected subset of 100 laws, due to cost).</span></p>
            <hr/>
            <h3>Statement 1: Tumor-Intrinsic Organ Adaptive Program Law</h3>
            <p><strong>Statement:</strong> Metastatic colonization and outgrowth within a specific organ requires that disseminated tumor cells possess, acquire, or reactivate context-appropriate transcriptional and/or epigenomic programs—including but not limited to: (a) stem-cell–like (WNT, HIPPO) and metabolic adaptation for liver; (b) neuronal/ECM mimicry and cell–cell junction adaptability in brain; (c) nuclear/cytoskeletal mechanics (e.g., LMNA downregulation) for tissues with high mechanical or confinement stress (e.g., liver); (d) EMT plasticity or osteomimicry for bone; often selected through in vivo lineage pressures or microenvironmental induction.</p>
            <p><strong>Domain/Scope:</strong> Applies primarily to the outgrowth phase of metastatic colonization (i.e., successful DTCs following arrest and initial survival) in all solid tumor organotropism contexts (liver, brain, bone, lung, etc.).</p>
            <h4>Special Cases</h4>
            <ol>
                <li>Some tumor types (e.g., SCLC, melanoma) display especially prominent transcriptional and epigenomic reprogramming; other tumors rely more heavily on pre-configured adaptation.</li>
                <li>Context-dependence: PMN and local selection pressures can induce or repress adaptive programs.</li>
            </ol>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>SCLC lines derived from liver metastases upregulate WNT-beta catenin and HIPPO stemness/metabolic programs, as well as show chromatin accessibility signatures for liver adaptation (RNA-seq, ATAC-seq); LMNA loss increases nuclear deformability and liver colonization specifically. <a href="../results/extraction-result-170.html#e170.2" class="evidence-link">[e170.2]</a> <a href="../results/extraction-result-170.html#e170.1" class="evidence-link">[e170.1]</a> </li>
    <li>SCLC and breast cancer lines from brain metastases upregulate neuronal identity and cell–cell/ECM junction programs, co-opting synaptic and astrocyte interactions required for brain colonization. <a href="../results/extraction-result-170.html#e170.3" class="evidence-link">[e170.3]</a> <a href="../results/extraction-result-176.html#e176.10" class="evidence-link">[e176.10]</a> <a href="../results/extraction-result-234.html#e234.1" class="evidence-link">[e234.1]</a> <a href="../results/extraction-result-234.html#e234.7" class="evidence-link">[e234.7]</a> </li>
    <li>Breast cancer bone-tropic cells activate osteomimicry, osteolytic or osteoblastic feedback programs (e.g., PTHrP, RANKL, etc.) for bone adaptation. <a href="../results/extraction-result-234.html#e234.2" class="evidence-link">[e234.2]</a> <a href="../results/extraction-result-173.html#e173.0" class="evidence-link">[e173.0]</a> <a href="../results/extraction-result-234.html#e234.3" class="evidence-link">[e234.3]</a> </li>
    <li>Epigenetic expansion in VHL-mutant RCC enables HIF output and metastatic activity across multiple sites. <a href="../results/extraction-result-234.html#e234.8" class="evidence-link">[e234.8]</a> </li>
</ol>            <h4>Self-Evaluation of Law Novelty (produced by the generation model)</h4>
            <p><strong>Likely Classification:</strong> <span style="color: orange; font-weight: bold;">somewhat-related-to-existing</span></p>
        <p><strong>Explanation:</strong> Mechanistic paradigm is not unique but formal assembly and alignment across many organs/tumor types is recent.</p>            <p><strong>What Already Exists:</strong> Organ-specific transcriptional and (epi)genomic adaptation is increasingly recognized in metastatic biology; published in SCLC, melanomas, breast cancer, and others.</p>            <p><strong>What is Novel:</strong> The law formalizes the necessity of adaptive, context-specific tumor-intrinsic programs as an enabling factor, not merely outcome, of successful organ-specific metastatic colonization, and links their selection to both in vivo pressure and microenvironmental cues.</p>
        <p><strong>References:</strong> <ul>
    <li>Lawson, JHC (2018) Functional heterogeneity in disseminated tumor cells [mechanotransduction and adaptation]</li>
    <li>Rudin (2022) Genomic and epigenomic features of SCLC organotropism [SCLC, liver, and brain adaptation]</li>
    <li>Vanharanta (2013) Epigenetic expansion in renal cell carcinoma metastasis [RCC, VHL, HIF, epigenetics]</li>
</ul>
            <h4>External Evaluations of this Law</h4>
            <p><strong>Predictive Accuracy Evaluation:</strong> <span class="empty-note">Not available.</span></p>
            <p><strong>Novelty Evaluation:</strong> <span class="empty-note">Not available (available only for a randomly selected subset of 100 laws, due to cost).</span></p>
            <hr/>
        </div>
        <div class="section">
            <h2>Theory (Additional Details)</h2>
                        <h3>New Predictions (Likely outcome)</h3>
            <ol>
                <li>Surgical rerouting of venous drainage (e.g., during colorectal surgery) will shift initial patterns of metastasis (e.g., raise lung over liver seeding).</li>
                <li>CRISPR or RNAi knockdown of critical organ-adaptive genes (e.g., stemness regulators, WNT/HIPPO, neuronal markers, LMNA) in matching tumor cells will abolish the ability to colonize and grow within the respective organs in animal models.</li>
                <li>Lineage tracing will show that the majority of overt metastases arise from subclones with pre-existing or rapidly plastic organ-adaptive gene expression.</li>
            </ol>
            <h3>New Predictions (Unknown outcome/high-entropy)</h3>
            <ol>
                <li>Reprogramming DTCs with non-endogenous adaptive programs (e.g., overexpression of 'wrong' adaptation genes) will induce ectopic (non-canonical) organ colonization when combined with appropriate PMN conditions.</li>
                <li>Single-cell omics trajectory mapping will reveal that microenvironmental signals (e.g., PMN chemokines, ECM cues) induce rapid switching of tumor cell identity at the point of extravasation.</li>
                <li>Blocking multiple axes (anatomical trapping, PMN, and adaptation) simultaneously will have a supra-additive effect in preventing organ-specific metastasis compared to any single-axis intervention.</li>
            </ol>
            <h3>Negative Experiments</h3>
            <ol>
                <li>Inhibition of all organ adaptation programs (e.g., LMNA, WNT, stemness) in tumor cells has no effect on metastatic organotropism—contradicting necessity.</li>
                <li>Human tumor samples from patients with unusual or ectopic metastatic spread will not show congruent adaptation programs relative to their host organ.</li>
                <li>Altering anatomical drainage routes does not affect organ-seeding distribution—contradicting anatomical determinant law.</li>
            </ol>
            <h3>Unaccounted for Evidence</h3>
<ol>
    <li>Situations where rare, stochastic events or co-migrating fusion hybrids (e.g., tumor–macrophage hybrids) impart new organ tropism not predicted by anatomy, PMN, or classic adaptive programs. <a href="../results/extraction-result-175.html#e175.4" class="evidence-link">[e175.4]</a> <a href="../results/extraction-result-175.html#e175.5" class="evidence-link">[e175.5]</a> <a href="../results/extraction-result-175.html#e175.8" class="evidence-link">[e175.8]</a> </li>
</ol>        </div>        <div style="height: 30px;"></div>
    </div>
</body>
</html>